Navigation Links
Perrigo's PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
Date:4/21/2011

ALLEGAN, Mich., April 21, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that the United States Court of Appeals for the fourth Circuit has affirmed an earlier decision that Mead Johnson had engaged in false advertising resulting in an injunction prohibiting Mead Johnson from making similar claims and awarding damages in favor of PBM.

Perrigo's Chairman and CEO Joseph C. Papa concluded, "We are pleased that the Appeals Court affirmed the District Court's decision in favor of PBM. The Court has made it clear that national brand and store brand suppliers are entitled to fairly compete and advertising abuses will not be tolerated. We also appreciate the Court's recognition that PBM could lawfully compare its products to national brand products."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.  The Company is the world's largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).  

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections.  While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 26, 2010, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Perrigo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
5. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
6. Leukemia Therapy With Imatinib During Pregnancy May Cause Infant Abnormalities
7. Pregnant Women Need Omega-3 to Boost Infant Development
8. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
9. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
10. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
11. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Global Insulin Needles Industry ... key companies and supported with 272 tables and ... on the current state of the Insulin Needles ... including definitions, classifications, applications and industry chain structure. ... the international market including development history, competitive landscape ...
(Date:5/3/2016)... , May 4, 2016 Research ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved significantly ... expected to be developed in coming years. Many cancer ... Cancer stem cell therapies are also expected to be ...
(Date:5/3/2016)... 3, 2016  As a teenager, an active and ... which damaged his heart. He continued enjoying sports and ... 2013, Shepherd,s heart was giving out and he was ... 20, 2013, the Mesa, Arizona ... Like a heart transplant, the SynCardia TAH-t is the ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... Logically, spring weather, with its moderate humidity and ... too cold, dry or hot, water on the eye surface can evaporate, creating uncomfortable ... surrounding air. There’s only one problem, according to radio show and water advocate Sharon ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to ... offering EarQ members the unique opportunity to learn more about Signia’s technology and the ... growth. , “It is our priority to see practices succeed in this highly competitive ...
(Date:5/6/2016)... ... ... is a speaker, author, and life strategy coach who is spreading the message of ... his publisher Strategic Book Group and its subsidiary Publish on Demand Global (PODG). ... He needed a heart and double-lung transplant. From this came a life-changing transformation that led ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... to Sleepopolis.com . , Since launching in September, 2014 Sleepopolis has resided ... testing areas, which now include pillows, sheets, mattress toppers, bed frames, and more. ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... doctors, worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl ... and it is his hope that the health and science industries will pay close attention ...
Breaking Medicine News(10 mins):